Safety and efficacy of ivacaftor in infants aged 1 to less than 4 months with cystic fibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and efficacy of ivacaftor in infants aged 1 to less than 4 months with cystic fibrosis

Published:2024-05 Issue:3 Volume:23 Page:429-435
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

McNally Paul^ORCID,Singh Alvin,McColley Susanna A.^ORCID,Davies Jane C.,Higgins Mark,Liu Meng,Lu Jennifer,Rodriguez-Romero Violeta^ORCID,Shih Judy L.,Rosenfeld Margaret^ORCID

Publisher

Elsevier BV

Reference11 articles.

1. Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770;Van Goor;Proc Natl Acad Sci U S A,2009

2. Ivacaftor potentiation of multiple CFTR channels with gating mutations;Yu;J Cyst Fibros,2012

3. Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation;Accurso;N Engl J Med,2010

4. Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2–5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study;Davies;Lancet Respir Med,2016

5. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation;Ramsey;N Engl J Med,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP